BIOTA PHARMACEUTIALS INC's ticker is BOTA and the CUSIP is 090694100. A total of 48 filers reported holding BIOTA PHARMACEUTIALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $831,000 | -18.7% | 554,005 | +5.1% | 0.00% | 0.0% |
Q4 2015 | $1,022,000 | +3.7% | 526,905 | +5.8% | 0.00% | 0.0% |
Q3 2015 | $986,000 | -18.4% | 497,805 | -14.8% | 0.00% | -33.3% |
Q2 2015 | $1,209,000 | -7.0% | 584,042 | +3.3% | 0.00% | 0.0% |
Q1 2015 | $1,300,000 | +12.1% | 565,262 | +9.1% | 0.00% | 0.0% |
Q4 2014 | $1,160,000 | +34.3% | 517,906 | +48.1% | 0.00% | +50.0% |
Q3 2014 | $864,000 | -5.6% | 349,605 | +8.9% | 0.00% | 0.0% |
Q2 2014 | $915,000 | -53.3% | 321,105 | +0.1% | 0.00% | -60.0% |
Q1 2014 | $1,961,000 | +48.7% | 320,905 | +1.9% | 0.01% | +66.7% |
Q4 2013 | $1,319,000 | -0.9% | 314,805 | -1.1% | 0.00% | 0.0% |
Q3 2013 | $1,331,000 | +22.0% | 318,347 | +0.6% | 0.00% | 0.0% |
Q2 2013 | $1,091,000 | – | 316,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 327,190 | $1,371,000 | 1.41% |
Healthcare Value Capital, LLC | 204,639 | $857,000 | 0.63% |
GABELLI & Co INVESTMENT ADVISERS, INC. | 387,048 | $1,622,000 | 0.59% |
TOWERVIEW LLC | 285,000 | $1,194,000,000 | 0.55% |
683 Capital Management, LLC | 450,000 | $1,886,000 | 0.54% |
Dominick & Dominick LLC | 88,089 | $369,000 | 0.18% |
Baker Brothers Advisors | 1,130,113 | $4,735,000 | 0.07% |
SHEPHERD KAPLAN KROCHUK, LLC | 50,299 | $211,000 | 0.03% |
Spark Investment Management LLC | 18,100 | $75,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 79,899 | $335,000 | 0.01% |